These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23047574)

  • 1. Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment).
    Kobylecka M; Mączewska J; Fronczewska-Wieniawska K; Mazurek T; Płazińska MT; Królicki L
    Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):52-60. PubMed ID: 23047574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of myocardial viability by FDG-PET].
    Momose M; Kondo C
    Rinsho Byori; 2007 Jul; 55(7):639-47. PubMed ID: 17718060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of myocardial viability by PET.
    Khalaf S; Chamsi-Pasha M; Al-Mallah MH
    Curr Opin Cardiol; 2019 Sep; 34(5):466-472. PubMed ID: 31393420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac positron emission tomography imaging.
    Machac J
    Semin Nucl Med; 2005 Jan; 35(1):17-36. PubMed ID: 15645392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocardial viability assessment and perioperative cardiovascular evaluation using single photon emission tomography and positron emission tomography].
    Yoshinaga K
    Kyobu Geka; 2007 Jul; 60(8 Suppl):627-34. PubMed ID: 17763661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
    Ghesani M; Depuey EG; Rozanski A
    Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI assessment of myocardial viability: comparison with other imaging techniques.
    Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H
    Rays; 1999; 24(1):96-108. PubMed ID: 10358387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT].
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Yonekura Y; Yamashita K; Konishi J; Ban T; Mikawa H
    J Cardiol; 1992; 22(1):21-6. PubMed ID: 1307567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac applications of PET.
    Sarikaya I
    Nucl Med Commun; 2015 Oct; 36(10):971-85. PubMed ID: 26035516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated anatomy and viability assessment PET-CT.
    Saraste A; Ukkonen H; Kajander S; Knuuti J
    EuroIntervention; 2010 May; 6 Suppl G():G132-7. PubMed ID: 20542819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results.
    Priamo J; Adamopoulos D; Rager O; Frei A; Noble S; Carballo D; Ratib O; Nkoulou R
    Nucl Med Commun; 2017 Jun; 38(6):515-522. PubMed ID: 28430739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in cardiovascular disease.
    Beanlands R
    Can J Cardiol; 1996 Oct; 12(10):875-83. PubMed ID: 9191475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of advanced cardiac imaging methods in coronary artery disease].
    Kiraç S
    Anadolu Kardiyol Derg; 2008 Jul; 8 Suppl 1():1-4. PubMed ID: 18611832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology].
    Z Kardiol; 1996 Jul; 85(7):453-68. PubMed ID: 8928543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 18FDG PET with thallium SPECT in the assessment of myocardial viability. A segmental model analysis.
    Alexánderson E; Ricalde A; Romero-Ibarra JL; Meave A
    Arch Cardiol Mex; 2006; 76(1):9-15. PubMed ID: 16749497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: a correlative PET study.
    Soufer R; Dey HM; Lawson AJ; Wackers FJ; Zaret BL
    J Nucl Med; 1995 Feb; 36(2):180-7. PubMed ID: 7830110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myocardial perfusion and viability by positron emission tomography.
    Anagnostopoulos C; Georgakopoulos A; Pianou N; Nekolla SG
    Int J Cardiol; 2013 Sep; 167(5):1737-49. PubMed ID: 23313467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.